SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-064786
Filing Date
2023-08-09
Accepted
2023-08-09 08:30:11
Documents
14
Period of Report
2023-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183023-8k_oramed.htm   iXBRL 8-K 54234
2 STOCK PURCHASE AGREEMENT DATED AS OF AUGUST 7, 2023, BETWEEN ORAMED PHARMACEUTIC ea183023ex2-1_oramed.htm EX-2.1 243806
3 SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-POSSESSION LOAN AND SECURITY AGREEMENT ea183023ex10-1_oramed.htm EX-10.1 486099
  Complete submission text file 0001213900-23-064786.txt   1117555

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ormp-20230807.xsd EX-101.SCH 3009
5 XBRL LABEL FILE ormp-20230807_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ormp-20230807_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183023-8k_oramed_htm.xml XML 3320
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 231153495
SIC: 2834 Pharmaceutical Preparations